Adaptive Biotechnologies ADPT Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
Based on trailing twelve months.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's net margin?
- Adaptive Biotechnologies (ADPT) reported net margin of -16.8% in Q1 2026.
- How has Adaptive Biotechnologies's net margin changed year-over-year?
- Adaptive Biotechnologies's net margin increased by 77.5% year-over-year, from -74.8% to -16.8%.
- What is the long-term trend for Adaptive Biotechnologies's net margin?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's net margin has grown at a -32.1% compound annual growth rate (CAGR), from -148.6% to -21.5%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.